10 withdrawn. 10 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Withdrawn 10 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Rhinitis, Allergic: new trials by email Literature Review of Rhinitis, Allergic trials Research Report on Rhinitis, Allergic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil Administration of investigation of Eurofarma drug, Administration of Comparator - Allergic Rhinitis | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2026-03-01 | 2025-12-18 | |
| Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis MAGNÓLIA NASAL GEL, MOMETASONE FUROATE - Allergic Rhinitis | Phase 3 | Withdrawn | EMS | 2022-08-01 | 2022-08-05 | |
| Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis Budesonid 50mcg (Noex), Budesonid 50mcg (Busonid) - Rhinitis, Allergic, Perennial | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2019-10-08 | 2019-10-09 | |
| Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis CPM, Placebo - Allergic Rhinitis, Nasal Congestion | Phase 2 / Phase 3 | Withdrawn | Larkin Community Hospital | 2019-07-30 | 2023-10-16 | |
| Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis EMS Mometasone gel, Mometasone spray nasal - Allergic Rhinitis | Phase 3 | Withdrawn | EMS | 2019-05-01 | 2020-11-04 | |
| Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis EMS Mometasone gel, Mometasone spray nasal - Allergic Rhinitis | Phase 3 | Withdrawn | EMS | 2019-05-01 | 2020-11-04 | |
| Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis Budesonide - Rhinitis, Allergic, Perennial | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2016-06-01 | 2019-10-09 | |
| Topical Allstate and Nasal Allergen Challenge Allstate Nasal Spray, Placebo Nasal Spray - Allergic Rhinitis | Phase 3 | Withdrawn | University of Chicago | 2011-11-01 | 2013-06-03 | |
| Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis Loratadine + Pseudoephedrine sulfate - Allergic Rhinitis | Phase 3 | Withdrawn | Azidus Brasil | 2010-01-01 | 2022-10-31 | |
| Lactobacillus Acidophilus L92 on Markers of Allergic Inflammation by Nasal Provocation With Grass Pollen Lactobacillus acidophilus L-92 - Hayfever | Phase 3 | Withdrawn | University of California, Davis | 2006-05-01 | 2015-04-22 |
Rhinitis, Allergic, Perennial (2) · Hypersensitivity (1) · Nasal Obstruction (1) · Rhinitis, Allergic, Seasonal (1)
Hypersensitivity, Immediate (10) · Immune System Diseases (10) · Nose Diseases (10) · Otorhinolaryngologic Diseases (10) · Respiratory Hypersensitivity (10) · Respiratory Tract Diseases (10) · Rhinitis (10) · Hypersensitivity (9) · Airway Obstruction (1) · Respiration Disorders (1) · Respiratory Insufficiency (1)
Mometasone Furoate (3) · Acetaminophen (1) · Budesonide (1) · Chlorpheniramine (1) · Loratadine (1)
EMS (3) · Eurofarma Laboratorios S.A. (3) · Azidus Brasil (1) · Larkin Community Hospital (1) · University of California, Davis (1) · University of Chicago (1)
Brazil (4) · United States (2)
Fu-Tong Liu, MD, PhD (1) · Marcos A Sanchez-Gonzalez (1) · Mauro Acir Crippa Junior (1) · Mauro Acir Crippa Junior, MD (1) · Robert M Naclerio, MD (1)